SCHEMBL8006555

SCHEMBL8006555

CCCCCCCCOCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 4/20 0.54
▸ ADORA2B P29275 5/20 0.53
▸ PDE4A P27815 3/20 0.53
▸ PDE4B Q07343 2/20 0.53
▸ PDE4C Q08493 2/20 0.53
▸ PDE4D Q08499 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ NFKB1 P19838 2/20 0.53
▸ ACHE P22303 2/20 0.53
▸ PMP22 Q01453 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ BCHE P06276 1/20 0.51
▸ ADORA2A P29274 1/20 0.50
▸ CHIT1 Q13231 1/20 0.49
▸ CHIA Q9BZP6 1/20 0.49
▸ ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8432861 0.96 TNF (0.56) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL6785565 0.90 ADORA2B (0.62) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8077198 0.90 ADORA2B (0.62) TNFADORA2BPDE4APDE4BPDE4C
Ammonia Solution, Strong SCHEMBL27840338 0.88 ADORA2B (0.60) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8434831 0.88 TNF (0.61) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8644659 0.87 TNF (0.55) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL9121598 0.87 ADORA2B (0.61) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8072448 0.85 ADORA2B (0.62) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL9294827 0.85 ADORA2B (0.62) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL9293740 0.85 ADORA2B (0.62) TNFADORA2BPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100271-A Therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-08-08 — — US disclosed
US-6043250-A Methods for using therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-03-28 — — US disclosed
US-5807862-A Therapeutic compounds containing pyrimidinyl moieties CELL THERAPEUTICS, INC. (US) 1998-09-15 — — US disclosed
US-5770595-A Oxime substituted therapeutic compounds CELL THERAPEUTICS, INC. (US) 1998-06-23 — — US disclosed
WO-1995020589-A1 CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1995-08-03 — — WO disclosed
Send feedback